Genmab Announces Positive Top-Line Phase II Results of Ofatumumab in Multiple Sclerosis
Oct 10, 2013 Genmab A/SCompany AnnouncementGenmab Announces Positive Top-Line Phase II Results of Ofatumumab in Multiple SclerosisCompany Announcement —…
2013 MS Symposium in Miami – Register to listen to this Live UPSTREAM Webcast
Click the Flyer to make larger. Click to register to attend ===================================================== Visit our…
Stuart Schlossman
Drug to treat multiple sclerosis may also hold promise for treating cardiac hypertrophy
July 17, 2013 A drug already approved to treat multiple sclerosis may also hold promise for treating cardiac hypertrophy, or thickening of…
Stuart Schlossman
IMPACT of MS on the Family plus Treatment Options
LAST date to RSVP for this Tampa program is Tuesday – July 16, 2013 Click flyer to enlarge and Click…
Stuart Schlossman
“I Touch Myself” Singer Chrissy Amphlett Has Died At Age 53
“I Touch Myself” Singer Chrissy Amphlett Has Died At Age 53 Mon, 22 Apr, 2013 10:47 AM PDT Chrissy Amphlett,…
Stuart Schlossman
Many myths surrounding multiple sclerosis today
Thursday, April 18, 2013 Recently, there have been stories in the Herald and News and on KOBI 5 about multiple…
Stuart Schlossman
To Receive Our MS Educational Information,,,
Near to the Top left of this blog page (where the articles begin) , it reads: REGISTER TO RECEIVE OUR…
Stuart Schlossman
Injectable Drug Demonstrates Efficacy with Reduced Dosing Schedule
An injectable treatment for relapsing-remitting MS (RRMS) designed to significantly reduce the dosing schedule typical of standard interferon drugs has…
Stuart Schlossman
MS VIEWS AND NEWS PROVIDES EDUCATIONAL INFORMATION TO THE GLOBAL MS COMMUNITY
TO SEE WHAT MS VIEWS AND NEWS PROVIDES, LOCALLY, NATIONALLY AND INTERNATIONALLY, PLEASE CLICK THIS LINK TO OPEN OUR FLYER:…
Stuart Schlossman
A Free MS Seminar in Spanish on SYMPTOM MANAGEMENT – May 23rd at 6pm
MS Views and News Invites you to this Multiple Sclerosis Educational Program SYMPTOM MANAGEMENT – MANEJO DE SINTOMAS FUTURE…
Stuart Schlossman
